跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MILRINONE LACTATE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MILRINONE LACTATE INJECTION USP
Authorized
STANDARD
MILRINONE LACTATE INJECTION USP
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ffc7ad6ee90a8a04
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
ffc7ad6ee90a8a04
Drug Approval Canada Name
MILRINONE LACTATE INJECTION USP
Product Name
MILRINONE LACTATE INJECTION USP
Status
Marketed
Status Date
2023-05-31
Original Market Date
2023-05-31
Din
02521407
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:04.08
Atc Original
C01CE02 MILRINONE
Atc Name
c 01 ce 02
Aig Number
0131285001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
MILRINONE (MILRINONE LACTATE)
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ffc7ad6ee90a8a04
Type
Standard
Back to Health Canada Approvals